Carlos Solano

39PUBLICATIONS
147CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Predictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Jul 17, 2026
Incidence, clinical risk factors, and biomarkers of SOS/VOD following allogeneic HSCT in adults. A real-life study by the Spanish group of HSCT and cell therapy (GETH-TC).

|Jun 19, 2026
The impact of IPI risk factors on CAR T-cell therapy or allogeneic stem cell transplantation for treatment of relapsed or refractory large B-cell lymphoma (LBCL).

|Jan 26, 2026
Microbiome-Based Modeling of CAR-T Therapy Response in Lymphoma: Insights From Shotgun Metagenomics Sequencing.

Rafael Hernani, Eliseo Albert, Carlos Hernani-Morales

|Jan 13, 2026
Allogeneic HCT as consolidation in B-cell lymphomas after exposure to bispecific antibodies: a GETH-TC study.

Marta Peña, Giulia Losi, Víctor Navarro

|Aug 28, 2025
Non-Viral Therapy in COVID-19: Where Are We Standing? How Our Experience with COVID May Help Us Develop Cell Therapies for Long COVID Patients.

Aitor Gonzaga, Gema Martinez-Navarrete, Loreto Macia

|Jul 25, 2025
Natural Killer (NK) Cell Alloreactivity in Haploidentical Stem Cell Transplantation.

Mar Luis-Hidalgo, José Luis Piñana, Carlos Solano

Pageof 7

Frequent Collaborators

16 joint publications

Dixie Huntley

13 joint publications

José Luis Piñana

12 joint publications

Juan Carlos Hernández-Boluda

7 joint publications

Jaime Sanz